Coronavirus Vaccine Update With Paul Offit – October 27, 2020
Coronavirus Vaccine Update With Paul Offit – October 27, 2020
Paul A. Offit, MD of the Children's Hospital of Philadelphia, returns to JAMA's Q&A series to provide an update on progress in #COVID19 vaccine development. Recorded October 27, 2020.Check out our video explaining the vaccine frontrunners at https://youtu.be/KMc3vL_MIeo
Topics discussed in this interview:
0:00 Introduction
0:43 Fall spike in cases
2:01 National masking mandate
4:16 Herd immunity and the Great Barrington Declaration
5:50 Vaccine and Related Biologic Products FDA Advisory Committee meeting
6:34 Emergency Use Authorizations (EUAs)
9:43 Is 2 months enough for safety data?
12:10 Next steps for FDA
14:25 Inactivated vaccine from China and Russian vaccine
15:49 Vaccine trials ethical considerations
17:26 COVID-19 vaccines in children
19:08 Vaccine timeline and the election
21:06 ACIP view on EUA applications
22:12 How we knew in 1955 that the polio vaccine was effective
24:11 Hurdles to vaccine distribution
• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire.
• Claim 0.5 credits for each video at https://ja.ma/covidqa
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwor
Follow the JAMA Network
• https://www.jamanetwork.com
• https://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #COVID19 #SARSCoV2 #Pandemic
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.